PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28359316-7	2017	BxPC3 and PANC-1 cells clearly migrated towards the concentration gradient formed by injecting 1 muL LPA, which was abrogated by pre-treatment with LPA inhibitor, Ki16425 (IC50 for the directionality   1.86 muM).	3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid	163-170	latexin	Homo sapiens	207-210	
25398768-3	2015	This involved lysophosphatidate type 1 (LPA1) receptors as identified with 1 muM wls-31 (LPA1/2 receptor agonist) and blocking this effect with 20 muM Ki16425 (LPA1-3 antagonist, Ki = 0.34 muM).	3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid	151-158	latexin	Homo sapiens	147-150	
25398768-3	2015	This involved lysophosphatidate type 1 (LPA1) receptors as identified with 1 muM wls-31 (LPA1/2 receptor agonist) and blocking this effect with 20 muM Ki16425 (LPA1-3 antagonist, Ki = 0.34 muM).	3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid	151-158	latexin	Homo sapiens	147-150